These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9456169)

  • 21. [Multiple phlebothrombosis following cesarean section due to heterozygous factor V Leiden mutation detected post partum].
    Grulich D; Schulze G; Riedel HH
    Zentralbl Gynakol; 1999; 121(11):526-9. PubMed ID: 10612220
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Resistance to activated protein C (APC): mutation at Arg506 of coagulation factor V and vascular access thrombosis in haemodialysis patients.
    Födinger M; Mannhalter C; Pabinger I; Koizar D; Rintelen C; Hörl WH; Sunder-Plassmann G
    Nephrol Dial Transplant; 1996 Apr; 11(4):668-72. PubMed ID: 8671856
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of activated protein C resistance in anticoagulated and lupus positive patients.
    Ivey LM; Thom JY; Ivey JG; Baker RI
    Blood Coagul Fibrinolysis; 2000 Jul; 11(5):439-45. PubMed ID: 10937805
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Stroke due to recurrent ipsilateral carotid artery dissection in a young adult.
    Goldstein LB; Gray L; Hulette CM
    Stroke; 1995 Mar; 26(3):480-3. PubMed ID: 7886728
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced response to activated protein C is associated with increased risk for cerebrovascular disease.
    van der Bom JG; Bots ML; Haverkate F; Slagboom PE; Meijer P; de Jong PT; Hofman A; Grobbee DE; Kluft C
    Ann Intern Med; 1996 Aug; 125(4):265-9. PubMed ID: 8678388
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticoagulant therapy after retinal vein occlusion in patients with protein S deficiency (Protein S deficiency with homozygous factor V Leiden mutation in central retinal vein occlusion. Vol. 42[4]).
    Rehak M; Krcova V; Slavik L; Müller M; Rehak J
    Can J Ophthalmol; 2007 Dec; 42(6):875; author reply 876. PubMed ID: 18059510
    [No Abstract]   [Full Text] [Related]  

  • 27. Multiple retinal arteriolar occlusions associated with coexisting primary antiphospholipid syndrome and factor V Leiden mutation.
    Dori D; Beiran I; Gelfand Y; Lanir N; Scharf J; Miller B; Brenner B
    Am J Ophthalmol; 2000 Jan; 129(1):106-8. PubMed ID: 10653428
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activated protein C resistance due to a factor V mutation associated with familial ischemic stroke.
    De Lucia D; Nina P; Papa ML; Belli A; Conte M; Renis V; Di Mauro C; Masi S; Franco A; Schisano G
    J Neurosurg Sci; 1997 Dec; 41(4):373-8. PubMed ID: 9555645
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recurrent ulcerations on both legs since early childhood due to a factor V gene mutation.
    Hackenjos K; Bek M; Schöpf E; Vanscheidt W
    Dermatology; 1997; 194(3):297-8. PubMed ID: 9187855
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The factor V Leiden mutation increases the risk of venous thrombosis in patients with inflammatory bowel disease.
    Liebman HA; Kashani N; Sutherland D; McGehee W; Kam AL
    Gastroenterology; 1998 Oct; 115(4):830-4. PubMed ID: 9753484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance to activated protein C: a major cause of inherited thrombophilia.
    Jensen R; Ens GE
    Clin Lab Sci; 1997; 10(4):219-22. PubMed ID: 10169621
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Meta-analysis of factor V Leiden and ischemic stroke in young adults: the importance of case ascertainment.
    Hamedani AG; Cole JW; Mitchell BD; Kittner SJ
    Stroke; 2010 Aug; 41(8):1599-603. PubMed ID: 20616326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mutation in the gene coding for coagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men.
    Ridker PM; Hennekens CH; Lindpaintner K; Stampfer MJ; Eisenberg PR; Miletich JP
    N Engl J Med; 1995 Apr; 332(14):912-7. PubMed ID: 7877648
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Post-varicella arteriopathy of childhood: natural history of vascular stenosis.
    Lanthier S; Armstrong D; Domi T; deVeber G
    Neurology; 2005 Feb; 64(4):660-3. PubMed ID: 15728288
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Anticoagulation may be beneficial in high risk factor V Leiden carriers.
    Baglin T; Baglin C; Brown K; Luddington R
    BMJ; 1998 Aug; 317(7155):416. PubMed ID: 9694774
    [No Abstract]   [Full Text] [Related]  

  • 36. Combined heterozygous plasminogen deficiency and factor V Leiden defect in the same kindred.
    Sartori MT; Simioni P; Patrassi GM; Theodoridis P; Tormene D; Girolami A
    Clin Appl Thromb Hemost; 2000 Jan; 6(1):36-40. PubMed ID: 10726047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is hormone replacement a risk factor for ischemic stroke in women with factor V Leiden mutation?
    Meschia JF; Biller J; Witt T; Greist A; Rhinehart SN
    Arch Neurol; 1998 Aug; 55(8):1137-9. PubMed ID: 9708966
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
    Price DT; Ridker PM
    Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inherited prothrombotic conditions and premature ischemic stroke: sex difference in the association with factor V Leiden.
    Margaglione M; D'Andrea G; Giuliani N; Brancaccio V; De Lucia D; Grandone E; De Stefano V; Tonali PA; Di Minno G
    Arterioscler Thromb Vasc Biol; 1999 Jul; 19(7):1751-6. PubMed ID: 10397694
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factor V Leiden and thrombotic complications in heparin-induced thrombocytopenia.
    Lee DH; Warkentin TE; Denomme GA; Lagrotteria DD; Kelton JG
    Thromb Haemost; 1998 Jan; 79(1):50-3. PubMed ID: 9459322
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.